Steven C. Quay
CIK: 0001008227
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ATOSSA THERAPEUTICS, INC.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jan 20, 2026ATOS
ATOSSA THERAPEUTICS, INC.
Award(A)Direct331.7K shares- - Jan 20, 2026ATOS
ATOSSA THERAPEUTICS, INC.
Award(A)Direct325.2K shares- - May 21, 2025ATOS
ATOSSA THERAPEUTICS, INC.
Purchase(P)Direct11.2K shares at avg. $0.88$10K - May 15, 2025ATOS
ATOSSA THERAPEUTICS, INC.
Award(A)DirectStock Option (right to buy)
1.4M shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 20, 2026 | ATOS ATOSSA THERAPEUTICS, INC. | Award(A) | 331,674 | - | $0 | Direct |
| Jan 20, 2026 | ATOS ATOSSA THERAPEUTICS, INC. | Award(A) | 325,203 | - | $0 | Direct |
| May 21, 2025 | ATOS ATOSSA THERAPEUTICS, INC. | Purchase(P) | 11,239 | $0.88 | $9,887 | Direct |
| May 15, 2025 | ATOS ATOSSA THERAPEUTICS, INC. | Award(A) Stock Option (right to buy) | 1,366,062 | - | - | Direct |
1-4 of 4 transactions
About QUAY STEVEN C
QUAY STEVEN C (SEC CIK 0001008227) files insider reports with the SEC as President & CEO of ATOSSA THERAPEUTICS, INC. (ATOS).
Signal8 holds 4 ownership filings by QUAY STEVEN C, all Form 4s, filed between May 16, 2025 and Jan 30, 2026. Those filings report 4 transactions, from May 15, 2025 to Jan 20, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on QUAY STEVEN C's filings is in SEATTLE, WA.
Recent filings by QUAY STEVEN C
Other insiders filing for ATOSSA THERAPEUTICS, INC. (ATOS)
- Steinhart Richard I, Director
- Chen Shu-Chih, Director
- Remmel H. Lawrence, Director
- Finn Jonathan, Director
- Galli Stephen J, Director
- Cigler Tessa, Director